MabVax Therapeutics Holdings Inc. | Ownership
Companies that own MabVax Therapeutics Holdings Inc.
Cambridge Investment Research Advisors, Inc.
1,030,310
11.5%
49,967
0.01%
06/30/2018
G1 Execution Services LLC
75,904
0.85%
75,904
0%
06/30/2018
Commonwealth Equity Services, Inc.
27,865
0.31%
15,662
0%
06/30/2018
Virtu Financial BD LLC
12,783
0.14%
12,783
0%
06/30/2018
UBS Securities LLC
11,889
0.13%
10,237
0%
06/30/2018
RBC Dominion Securities, Inc. (Investment Management)
2,999
0.03%
0
0%
06/30/2018
Invesco Capital Management LLC
2,068
0.02%
0
0%
09/05/2018
Centerpoint Advisors LLC
203
0%
0
0%
06/30/2018
Securities America Advisors, Inc.
2
0%
0
0%
06/30/2018
Financial Architects, Inc.
2
0%
0
0%
06/30/2018
| Address |
11535 Sorrento Valley Road
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.mabvax.com |
| Updated |
09/14/2018 |
| MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. . |
